Cardinal Health, Inc. (CAH) Revenue by Segment

Cardinal Health revenue by segment at a glance

In Q3 fiscal 2026 (the quarter ended March 31, 2026), Cardinal Health's largest business segment was Pharmaceutical and Specialty Solutions, with $56.11 billion or 92% of revenue, up 11.3% from a year earlier. Next: GMPD (5%) and All other segments (3%).

By region, United States brought in 99% and Non-US brought in 1% of revenue in Q3 fiscal 2026.

By country, UNITED STATES brought in 99% and Non-US brought in 1% of revenue in Q3 fiscal 2026.

The fastest-growing business segment from a year earlier was Pharmaceutical and Specialty Solutions (+11.3%).

From company filings, in USD; latest quarter ended March 31, 2026; quarterly data from Q1 fiscal 2018.

Cardinal Health, Inc.

CAHHealthcare

United States

Healthcare

Revenue breakdown

Fiscal quarters, from company filings

Segments by quarter (USD)

Click a bar to see that period below. Striped bars are calculated fourth quarters; an empty slot means it could not be calculated on the same basis i

Pharmaceutical and Specialty SolutionsMedicalGmpdAll other segments

Q4 FY26 breakdown

Fiscal quarter ended Jun 30, 2026 · calculated (full year minus the other periods)

Item	Revenue	Share	vs year before
Pharmaceutical and Specialty Solutionscalc	USD 58.85B	92.4%	+6.3%
Gmpdcalc	USD 3.13B	4.9%	-2.2%
All other segmentscalc	USD 1.72B	2.7%	+7.0%
Corporate and othericalc	-USD 25.00M		–

Sum of items USD 63.70B; corporate items and eliminations -USD 25.00M. Shares are of the items shown. Click an item with › to see its parts.

Also reported by:

All periods

Every item and period in one grid. Purple = calculated; "–" = not available.

Item	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24	Q1 FY24	Q4 FY23	Q3 FY23	Q2 FY23	Q1 FY23	Q4 FY22	Q3 FY22	Q2 FY22	Q1 FY22	Q4 FY21	Q3 FY21	Q2 FY21	Q1 FY21	Q4 FY20	Q3 FY20	Q2 FY20	Q1 FY20	Q4 FY19	Q3 FY19	Q2 FY19	Q1 FY19	Q4 FY18	Q3 FY18	Q2 FY18	Q1 FY18
Pharmaceutical and Specialty Solutions	58.8B	56.1B	60.7B	59.2B	55.4B	50.4B	50.8B	48.0B	55.6B	50.6B	53.2B	50.6B	–	46.5B	47.7B	45.8B	–	41.0B	41.4B	39.8B	–	35.1B	37.2B	35.1B	33.2B	35.1B	35.7B	33.4B	33.4B	31.4B	33.7B	31.4B	31.5B	29.7B	31.1B	28.9B
Medical	–	–	–	–	–	–	–	–	–	–	–	–	–	–	3.8B	3.8B	–	3.9B	4.1B	4.1B	–	4.2B	4.3B	4.0B	3.5B	4.1B	4.0B	3.9B	4.0B	3.9B	4.0B	3.8B	3.9B	3.9B	4.0B	3.7B
Gmpd	3.1B	3.1B	3.3B	3.2B	3.2B	3.2B	3.2B	3.1B	3.1B	3.1B	3.1B	3.0B	–	3.0B	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
All other segments	1.7B	1.7B	1.7B	1.6B	1.6B	1.3B	1.3B	1.2B	1.2B	1.2B	1.1B	1.1B	–	1.0B	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–

Cardinal Health revenue by business segment, last 4 quarters

Business segment	Q3 FY26	Q2 FY26	Q1 FY26	Q3 FY25	Share
Pharmaceutical and Specialty Solutions	$56.1B	$60.7B	$59.2B	$50.4B	92%
GMPD	$3.1B	$3.3B	$3.2B	$3.2B	5%
All other segments	$1.7B	$1.7B	$1.6B	$1.3B	3%

In USD, fiscal quarters as reported; share = part of Q3 FY26 revenue.

Cardinal Health revenue by region, last 4 quarters

Region	Q3 FY26	Q2 FY26	Q1 FY26	Q3 FY25	Share
United States	$60.5B	$65.2B	$63.6B	$54.5B	99%
Non-US	$423.0M	$435.0M	$419.0M	$399.0M	1%

In USD, fiscal quarters as reported; share = part of Q3 FY26 revenue.

Cardinal Health revenue by country, last 4 quarters

Country	Q3 FY26	Q2 FY26	Q1 FY26	Q3 FY25	Share
UNITED STATES	$60.5B	$65.2B	$63.6B	$54.5B	99%
Non-US	$423.0M	$435.0M	$419.0M	$399.0M	1%

In USD, fiscal quarters as reported; share = part of Q3 FY26 revenue.

Questions and answers

What are Cardinal Health's business segments?

Pharmaceutical and Specialty Solutions, GMPD and All other segments (as reported for Q3 fiscal 2026).

Which business segment makes the most money for Cardinal Health?

Pharmaceutical and Specialty Solutions: $56.11 billion, or 92% of revenue, in Q3 fiscal 2026.

Where does Cardinal Health make its money?

By region in Q3 fiscal 2026: United States (99%) and Non-US (1%).

MoreCardinal Health stock overview Cardinal Health financials Cardinal Health executive team Cardinal Health shareholders

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.

Segments by quarter (USD)

Click a bar to see that period below. Striped bars are calculated fourth quarters; an empty slot means it could not be calculated on the same basis i

Pharmaceutical and Specialty SolutionsMedicalGmpdAll other segments

Q4 FY26 breakdown

Fiscal quarter ended Jun 30, 2026 · calculated (full year minus the other periods)

Item	Revenue	Share	vs year before
Pharmaceutical and Specialty Solutionscalc	USD 58.85B	92.4%	+6.3%
Gmpdcalc	USD 3.13B	4.9%	-2.2%
All other segmentscalc	USD 1.72B	2.7%	+7.0%
Corporate and othericalc	-USD 25.00M		–

Sum of items USD 63.70B; corporate items and eliminations -USD 25.00M. Shares are of the items shown. Click an item with › to see its parts.

Also reported by:

All periods

Every item and period in one grid. Purple = calculated; "–" = not available.

Item	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24	Q1 FY24	Q4 FY23	Q3 FY23	Q2 FY23	Q1 FY23	Q4 FY22	Q3 FY22	Q2 FY22	Q1 FY22	Q4 FY21	Q3 FY21	Q2 FY21	Q1 FY21	Q4 FY20	Q3 FY20	Q2 FY20	Q1 FY20	Q4 FY19	Q3 FY19	Q2 FY19	Q1 FY19	Q4 FY18	Q3 FY18	Q2 FY18	Q1 FY18
Pharmaceutical and Specialty Solutions	58.8B	56.1B	60.7B	59.2B	55.4B	50.4B	50.8B	48.0B	55.6B	50.6B	53.2B	50.6B	–	46.5B	47.7B	45.8B	–	41.0B	41.4B	39.8B	–	35.1B	37.2B	35.1B	33.2B	35.1B	35.7B	33.4B	33.4B	31.4B	33.7B	31.4B	31.5B	29.7B	31.1B	28.9B
Medical	–	–	–	–	–	–	–	–	–	–	–	–	–	–	3.8B	3.8B	–	3.9B	4.1B	4.1B	–	4.2B	4.3B	4.0B	3.5B	4.1B	4.0B	3.9B	4.0B	3.9B	4.0B	3.8B	3.9B	3.9B	4.0B	3.7B
Gmpd	3.1B	3.1B	3.3B	3.2B	3.2B	3.2B	3.2B	3.1B	3.1B	3.1B	3.1B	3.0B	–	3.0B	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
All other segments	1.7B	1.7B	1.7B	1.6B	1.6B	1.3B	1.3B	1.2B	1.2B	1.2B	1.1B	1.1B	–	1.0B	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–